BRIEF published on 07/09/2024 at 12:35, 3 months 29 days ago Immunic nomme Jason Tardio au poste de directeur de l'exploitation et président Sclérose En Plaques Vidofludimus Calcium Nomination Du COO Immunitaire Jason Tardio
BRIEF published on 07/09/2024 at 12:35, 3 months 29 days ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Multiple Sclerosis Immunic Vidofludimus Calcium COO Appointment Jason Tardio
PRESS RELEASE published on 07/09/2024 at 12:30, 3 months 29 days ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 5 months 10 days ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
BRIEF published on 05/28/2024 at 12:35, 5 months 10 days ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
PRESS RELEASE published on 05/28/2024 at 12:30, 5 months 10 days ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 5 months 30 days ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
BRIEF published on 05/08/2024 at 12:35, 5 months 30 days ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
PRESS RELEASE published on 05/08/2024 at 12:30, 5 months 30 days ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF published on 05/06/2024 at 12:35, 6 months 1 day ago Immunic AG annonce sa participation aux conférences de mai destinées aux communautés d'investisseurs et scientifiques Essais Cliniques Conférences Investisseurs Immunic SA Conférences Scientifiques Traitements Des Maladies Auto-immunes
Published on 11/08/2024 at 10:00, 1 hour 14 minutes ago BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 2 hours 14 minutes ago Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 4 hours 14 minutes ago Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 8 hours 14 minutes ago Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 9 hours 49 minutes ago PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement
Published on 11/08/2024 at 11:06, 8 minutes ago Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/08/2024 at 11:00, 14 minutes ago BluSky Carbon CEO Presents a Case for ClimateTech Optimism
Published on 11/08/2024 at 10:43, 31 minutes ago Change of leadership at Hannover Re: Chief Executive Officer Jean-Jacques Henchoz hands over to Clemens Jungsthöfel on 1 April 2025
Published on 11/08/2024 at 10:40, 34 minutes ago EQS-Adhoc: Hannover Rück SE: Chief Executive Officer Jean-Jacques Henchoz hands over to Clemens Jungsthöfel on 1 April 2025
Published on 11/08/2024 at 08:00, 3 hours 14 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 16 hours 14 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 16 hours 14 minutes ago ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 14 minutes ago ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 14 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
